PHS FOI 2026-002412

Date of request
22 May 2026
Date of response
10 June 2026
FOI request ID
PHS FOI 2026-002412
  • Coronavirus (COVID-19)

Request

‘‘Thank you for your response regarding incidents associated with Pfizer-BioNTech COVID-19 vaccine batch FN1664.

 I would now like to request anonymised summary descriptions for each of the seven programmatic adverse events/incidents already identified.

 For each incident, please provide, where held:

  • A brief narrative summary describing the nature of the incident
  • Any identified cause or contributing factor
  • Whether any corrective action, recommendation, or procedural change followed
  • Whether the incident involved:
    • administration after expiry
    • incorrect preparation or dilution
    • storage or handling concerns
    • cold-chain deviation
    • patient monitoring or clinical follow-up
    • vaccine wastage

I am not requesting names, exact dates, CHI numbers, staff identifiers, or any directly identifying personal data.

As these incidents have already been identified and categorised, and I am requesting summary-level anonymised information only, this request should remain within cost limits and compatible with Section 38 anonymisation requirements under FOISA.’’

Response

Last updated: 11 June 2026